Investor Relations
The English version of Hemtex Investment Relations site is not being updated, due to the current shareholder structure. Please visit our Swedish Investment Relations site for updated information

Statement of comprehensive income, Group

January 1–December 31   Group
SEK 000s Note 2009* 2010
Net sales 2 916,836 1,080,775
Other operating income 3 7,883 11,782
Total operating income   924,719 1,092,557
       
Operating expenses      
Goods for resale 21 – 450,339 – 506,596
Other external costs 5 – 306,800 – 452,539
Personnel expenses 4 – 234,991 – 321,060
Depreciation/amortization and impairment of tangible and intangible assets 6 – 80,631 – 45,022
Operating loss 7, 25 – 148,042 – 232,660
       
Result from financial items    
Financial income   90 117
Financial expenses   – 3,633 – 7,361
Net financial items 8 – 3,543 – 7,244
       
Loss after financial items – 151,585 – 239,904
       
Tax on profit for the year 10 30,320 – 15,629
Net loss for the year   – 121,265 – 255,533
       
Other comprehensive income      
Translation differences   436 1,726
Comprehensive income for the year   – 120,829 – 253,807
       
Net loss for the year attributable to:      
Parent Company’s shareholders   – 121,265 – 255,533
Non-controlling interests  
       
Comprehensive income for the year attributable to:      
Parent Company’s shareholders   – 120,829 – 253,807
Non-controlling interests  
       
Earnings per share before dilution, SEK 11 – 3.04 – 6.22
Earnings per share after dilution, SEK   – 3.04 – 6.22
Number of shares outstanding on closing date   41,072,360 41,072,360
Average number of shares outstanding   39,824,821 41,072,360
Average number of shares outstanding after dilution   39 824 821 41 072 360
       
* Pertains to the abbreviated May to December 31, 2009 fiscal year.